APA Blogs
8 Results
How AI is Being Used in Psychiatry: An APA Member Survey
A new survey of members of the American Psychiatric Association (APA), finds that while most psychiatrists do not use AI in their practice today, many of those who do are optimistic about the potential of AI in psychiatry.
Need a Break from Social Media and AI Chatbots? Here’s How to Do it
- By John Torous, M.D., and Nicole M. Benson, M.D., MBI
Whether you are a teen or anyone who has ever used social media (more than 80% of the US population (1)) or tried an AI chatbot, you’ve probably noticed two digital forces pulling for your attention at the same time: social media feeds that never end and AI chatbots that always want to answer. Neither is inherently “good” or “bad.” But both can quietly reshape mood, sleep, stress, and how you cope, especially when they become the default way to unwind, vent, or avoid hard feelings. Up to 95% of teenagers are active online (2).
Vocal Biomarkers for Mental Health: Diagnosing Mental Disorders with a Short Voice Recording
Researchers are exploring the use of speech and voice analysis, assisted by artificial intelligence, to help diagnose depression and other mental illnesses. While not yet ready for use in practice, the research on the potential effectiveness and uses of artificial intelligence-driven speech and voice analysis as a biomarker for mental health conditions continues to accumulate.
What Are the Latest Scientific Trends in Psychiatry and How Will They Impact Care?
Scientific advancements and technology are giving psychiatrists increasing abilities to deliver treatments tailored to individual needs. Some of these include advancements in the areas of genetics, biomarkers and imaging.
An App for Therapy? Exploring Digital Therapeutics
In May 2024, the Food and Drug Administration approved the first app for the treatment of depression, Rejoyn. This new smartphone app is intended to help treat people who don’t fully respond to antidepressants and it is expected to be available for patients starting this summer. This is the latest in a series of FDA approvals of digital therapeutics for mental health conditions